Effect of γ-linolenic acid on cellular uptake of structurally related anthracyclines in human drug sensitive and multidrug resistant bladder and breast cancer cell lines

European Journal of Cancer

Volumn 35, Issue 10, 1999, Pages 1534-1540

  Davies, C L ^a,b   Loizidou, M ^a   Cooper, A J ^a   Taylor, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Anthracycline; Bladder cancer; Breast cancer; GLA; Multidrug resistance

Indexed keywords

DOXORUBICIN; EPIRUBICIN; GAMMA LINOLENIC ACID; IDARUBICIN; MITOXANTRONE;

ARTICLE; BLADDER CANCER; BREAST CANCER; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 0032832971     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00181-1     Document Type: Article

References (20)

1. Guffy MM, North JA, Burns CP. Effect of cellular fatty acid alteration on adriamycin sensitivity in cultured L1210 murine leukaemia cells. Cancer Res 1984, 44, 1863-1866.
2. Kinsella JE, Black JM. Effects of polyunsaturated fatty acids on the efficacy of antineoplastic agents toward L5178Y lymphoma cells. Biochem Pharmacol 1993, 45(9), 1881-1887.
3. Sangeetha Sagar P, Das UN. Gamma-linolenic acid and eicosapentaenoic acid potentiate the cytotoxicity of anti-cancer drugs on human cervical carcinoma (HeLa) cells in vitro. Med Sci Res 1993, 21, 457-459.
4. Burns CP, Haugstad BN, Mossman CJ, North JA, Ingraham LM. Membrane lipid alteration: effect on cellular uptake of mitoxantrone. Lipids 1988, 23(5), 393-397.
5. Timmer-Bosscha H, Hospers GAP, Meijers C, et al. Influence of docosahexanoic acid on cisplatin resistance in a human small cell lung carcinoma cell line. J Natl Cancer Inst 1989, 81, 1069-1075.
6. Neades GT, Jones DL, Hughes LE. Effect of polyunsaturated fatty acids on doxorubicin sensitivity in MCF-7 cells. Br J Surg (SRS Abstract) 1991, 78(6), 749.
7. McGovern F, Kachel T, Vijan S, Schiff S, et al. Establishment and characterisation of a doxorubicin-resistant human bladder cancer cell line (MGH-U1R). J Ural 1998, 140, 410-414.
8. Fairchild CR, Ivy PS, Kao-Shan C-S, et al. Cancer Research 1987, 47, 5141.
9. Plumb JA, Luo W, Kerr DJ. Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicin. Br J Cancer 1993, 67, 728-733.
10. Coley HM, Amos WB, Twentyman PR, Workman P. Examination by laser scanning confocal fluorescence imaging microscopy of the subcellular localisation of anthracyclines in parent and multidrug resistant cell lines. Br J Cancer 1993, 67, 1316-1323.
11. Duffy PM, Hayes MC, Gatrell SKE, Cooper A, Smart CJ. Determination and reversal of resistance to epirubicin intravesical chemotherapy. A confocal imaging study. Br J Urol 1996, 77, 824-829.
12. Jennings AM, Solomon LZ, Sharpe P, et al. Estramustine reversal of resistance to epirubicin chemotherapy. Eur Urol 1999, 35, 327-335.
13. Solomon LZ, Jennings AM, Sharpe P, Birch BR, Cooper AJ. Interaction of meglumine gamma linolenic acid with epirubicin and mitomycin C: implications for combination use in superficial bladder cancer. Br J Urol 1998, 81 (Suppl. 4), 26.
14. Das UN, Madhavi N, Sravan Kumar G, Padma M, Sangeetha P. Can tumour cell drug resistance be reversed by essential fatty acids and their metabolites? Prostaglandins, Leukotrines and Essential Fatty Acids 1998, 58(1), 39-54.
15. Das UN. Cis-unsaturated fatty acids as potential anti-mutagenic, tumoricidal and antimetastatic agents. Asia Pacific J Pharmacol 1992, 7, 305-327.
16. Chambers TG, Zheng B, Kuo JF. Regulation by phorbol ester and protein kinase C inhibitors, and by a protein phosphatase inhibitor (okadaic acid), of p-glycoprotein phosphorylation and relationship to drug accumulation in multidrug resistance human KB cells. Mol Pharmacol 1992, 41(6), 1008-1015.
17. Myers CE, McGuire WP, Liss RH, et al. Adriamycin: the role of lipid peroxidation in cardiac toxicity and tumour response. Science 1977, 197, 165-169.
18. Burns CP, Wagner BA. Effects of exogenous lipids on cancer and cancer chemotherapy: implications for treatment. Drug Safety 1993, 8(1), 57-68.
19. Lowe SW, Bodis S, McClatchey A. p53 status and the efficacy of cancer therapy in vivo. Science 1994, 266, 807-810.
20. Tillotson JK, Darzynkiewicz Z, Cohen LA, Ronai Z. Effects of linolenic acid on mammary tumour cell proliferation are associated with changes in p53 protein expression. Int J Oncol 1993, 3, 81-87.